A brief measure for assessing generalized anxiety disorder -: The GAD-7

被引:20373
作者
Spitzer, Robert L.
Kroenke, Kurt
Williams, Janet B. W.
Loewe, Bernd
机构
[1] New York State Psychiat Inst & Hosp, Biometr Res Dept, New York, NY 10032 USA
[2] Columbia Univ, Dept Psychiat, New York, NY USA
[3] Indiana Univ, Regenstrief Inst Hlth Care, Indianapolis, IN 46204 USA
[4] Indiana Univ, Dept Med, Indianapolis, IN 46204 USA
[5] Heidelberg Univ, Dept Psychosomat & Gen Internal Med, Heidelberg, Germany
关键词
D O I
10.1001/archinte.166.10.1092
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Generalized anxiety disorder (GAD) is one of the most common mental disorders; however, there is no brief clinical measure for assessing GAD. The objective of this study was to develop a brief self-report scale to identify probable cases of GAD and evaluate its reliability and validity. Methods: A criterion-standard study was performed in 15 primary care clinics in the United States from November 2004 through June 2005. Of a total of 2740 adult patients completing a study questionnaire, 965 patients had a telephone interview with a mental health professional within 1 week. For criterion and construct validity, GAD self-report scale diagnoses were compared with independent diagnoses made by mental health professionals; functional status measures; disability days; and health care use. Results: A 7-item anxiety scale (GAD-7) had good reliability, as well as criterion, construct, factorial, and procedural validity. A cut point was identified that optimized sensitivity (89%) and specificity (82%). Increasing scores on the scale were strongly associated with multiple domains of functional impairment (all 6 Medical Outcomes Study Short- Form General Health Survey scales and disability days). Although GAD and depression symptoms frequently co-occurred, factor analysis confirmed them as distinct dimensions. Moreover, GAD and depression symptoms had differing but independent effects on functional impairment and disability. There was good agreement between self- report and interviewer-administered versions of the scale. Conclusion: The GAD-7 is a valid and efficient tool for screening for GAD and assessing its severity in clinical practice and research.
引用
收藏
页码:1092 / 1097
页数:6
相关论文
共 32 条